Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(22)00442-x
PubMed Identifier: 36087586
Publication URI: http://europepmc.org/abstract/MED/36087586
Type: Journal Article/Review
Volume: 22
Parent Publication: The Lancet. Infectious diseases
Issue: 12
ISSN: 1473-3099